Lyell Immunopharma Unearned Premium on Insurance Contract (Quarterly) Trends

Lyell Immunopharma, Inc. (LYEL)

25.07 -0.77 (-2.98%) USD | NASDAQ | Jan 23, 16:00

25.07 0.00 (0.00%) After-Hours: 20:00

View Unearned Premium on Insurance Contract (Quarterly) for LYEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Nektar Therapeutics	--
GT Biopharma, Inc.	--
Ionis Pharmaceuticals, Inc.	--
Regeneron Pharmaceuticals, Inc.	--